Host immune response and inflammatory signaling

Host immune response and inflammatory signaling represent the integrated biological processes by which an organism detects and responds to harmful stimuli, such as pathogens, damaged cells, or irritants (Source: StatPearls, "Physiology, Inflammation"). This system relies on a vast array of molecular components, including pattern recognition receptors (PRRs), cytokines, chemokines, and intracellular signaling transducers like the Janus kinases (JAKs) and Nuclear Factor-kappa B (NF-κB) (Source: PubMed, PMC4056320). While these pathways are critical for host defense and tissue homeostasis, their chronic or systemic overactivation is central to the pathogenesis of numerous conditions, including rheumatoid arthritis, inflammatory bowel disease, and sepsis (Source: Nature Reviews Immunology, "Inflammation, transition from innate to adaptive immunity"). Pharmacological modulation of these signaling pathways aims to restore balance by inhibiting specific pro-inflammatory mediators or enhancing regulatory mechanisms (Source: PubChem, "Anti-Inflammatory Agents"). Common therapeutic strategies include the use of monoclonal antibodies against cytokines like TNF-alpha or IL-6, as well as small molecule inhibitors targeting downstream signaling enzymes (Source: NIH, "Immune System and Inflammation"). These interventions are designed to dampen excessive inflammation while attempting to preserve the host's ability to fight infections. However, the broad nature of these pathways often leads to challenges in achieving tissue-specific modulation without systemic side effects.

Other names

Host immune response / inflammatory signalingImmune signalingInflammatory cascadeHost defense responseCytokine signaling pathways

Modulation of inflammatory cascades through the inhibition of pro-inflammatory cytokines, antagonism of immune receptors, or blockade of intracellular signaling transducers such as Janus kinases (Source: PubMed, PMC4056320).